10x Genomics Lifts 2026 Revenue Forecast to $610M-$630M on Strong Shipments
The biotech firm raised its full-year revenue outlook after Q2 revenue reached $151 million, including a $1.6 million settlement item. 10x Genomics increased its 2026 revenue guidance to a range of $610 million to $630 million, citing sustained demand for its Atera systems